The following amendments have been made to the Directors Shareholding/PDMR announcement released on 4 November 2025 at 15:30 under RNS No 1674G.
All other details remain the same.
Hunting PLC
("Hunting" or "the Company")
Director Shareholding/PDMR
Hunting today announces the following share purchases by the Finance Director of the Company.
PDMR
Position
Number of shares purchased
Beneficial Holding
Bruce Ferguson
Finance Director
2,745
429,870
The Company was informed on 5 November that the Finance Director had purchased Hunting PLC Ordinary shares of 25p each at a price of 347.98 pence per share from cash received from a dividend reinvestment plan operating under a nominee account. The purchase took place on 3 November 2025.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Bruce Ferguson
2
Reason for the notification
a)
Position/status
Finance Director
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hunting PLC
b)
LEI
2138008S5FL78ITZRN66
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 25p each
Identification code
ISIN:- GB0004478896
b)
Nature of the transaction
Purchase of Ordinary Shares of 25p each from cash received from dividend payment
c)
Price(s) and volume(s)
Price(s)
Volume(s)
347.98 pence
2,745 Ordinary Shares
d)
Aggregated information
- Aggregated volume
2,745
- Price
347.98pence
e)
Date of the transaction
3 November 2025
f)
Place of the transaction
London / XLON
For further information please contact:
Ben Willey, Company Secretary
020 7321 0123
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHDZMGMFKNGKZM
